Sphaira
About Sphaira
Sphaira is a global team of experts specializing in autonomous mobility, medical technology, and innovation, with locations in Berlin, Germany and Cambridge, Massachusetts. Founded in 2020, the company has grown to a diverse team of 12 representing eight different nationalities. The name Sphaira, derived from Ancient Greek, symbolizes protection of the world's diversity and human connection, reflecting the company's mission to protect and assist isolation patients and their loved ones.
Founder and Vision
Founded by Janis Münch, who brings a background in software engineering, entrepreneurship, and healthcare technology innovation, Sphaira integrates Germany's rich mobility heritage with cutting-edge technological theory. The company's core values include fostering community, promoting mobility, creating impact, and safeguarding our shared home.
Core Product - MOBY® P1
Sphaira develops the MOBY® P1, a pioneering mobile protective vehicle designed to ensure physical protection and germ-proof isolation for high-risk medical cases. It surpasses typical hospital isolation standards and is certified as a Class I medical device under EU Medical Device Regulation. The MOBY® P1 offers improved outcomes for isolation patients by enabling safe intra-hospital transport and maintaining human contact, which enhances the quality of life and emotional support for patients and caregivers.
Technical and Usage Highlights
The MOBY® P1 is equipped with high-grade air filtration using dual HEPA filters, a 360-degree visibility canopy, active and passive electric drive, modular access ports for treatment, clear digital communication systems, and sensitive ergonomic seating. It is engineered to meet stringent cleanroom class standards comparable to NASA settings and features specifications tuned for patient comfort and safety.
Careers and Opportunities
Sphaira is actively seeking talent to join their mission to transform healthcare. Open positions and career opportunities can be explored on their careers page to support innovation in medical isolation and autonomous patient mobility.